About Biotectix
Biotectix is a company based in Hanau (Germany) founded in 2007 by Chris Silva, Sarah Richardson, Mark Pritchard, and Dave Martin was acquired by Heraeus in September 2017. Biotectix has raised $3 million across 2 funding rounds from investors including Heraeus, Allied Minds and Ann Arbor SPARK.
- Headquarter Hanau, Germany
- Founders Chris Silva, Sarah Richardson, Mark Pritchard, Dave Martin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biotectix
Biotectix has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biotectix
Biotectix has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Heraeus, Allied Minds and Ann Arbor SPARK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused seed and early-stage VC firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Materials for multiple industries are developed by Heraeus.
|
Locked | Locked | Locked |
Investor details for Biotectix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotectix
Investment portfolio details for Biotectix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biotectix
Detailed financials for Biotectix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotectix Comparisons
Peer comparison for Biotectix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biotectix
Detailed competitors of Biotectix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotectix
Complete news archive for Biotectix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotectix
Biotectix was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Biotectix is headquartered in Hanau, Germany. It is registered at Hanau, Hessen, Germany.
Biotectix is a funded company, having raised a total of $3M across 2 funding rounds to date.
Biotectix is developing conductive polymer materials, hydrogels and coatings for electrodes used in implantable and external medical devices and sensors such as pacemakers, cortical probes, cochlear implants, glucose sensors, and deep brain stimulators.. The company claims that the benefits of this technology include improved electrical performance, biocompatibility, and tissue response. The company offers its products to medical device manufacturers. Biotectix is a subsidiary of Allied Minds (London Stock Exchange: ALM).
Biotectix has 3 investors. Key investors include Heraeus, Allied Minds, and Ann Arbor SPARK.